Methylfolate is one of a handful of supplements with better quality data showing it could be useful as a possible adjunct treatment for major depressive disorder in addition to standard treatment.
Genetic testing to determine cancer risk Genetic testing can be used to identify patients who would benefit from L-methylfolate adjunctive therapy with antidepressants. Patients with ...
June 1, 2010 (New Orleans, Louisiana) — Combining an L-methylfolate prescription medical food supplement (Deplin, Pamlab) with a selective serotonin reuptake inhibitor (SSRI) or a serotonin ...
SAN FRANCISCO — Metabolic biomarkers may help identify differences in response to adjunctive L-methylfolate in patients with major depressive disorder (MDD), new research analysis suggests. In the ...
A new large review of the scientific evidence suggests that most dietary supplements don’t do much to help people suffering from mental health disorders. Supplements are often touted as something like ...
Treatment-resistant major depressive disorder has a significant presence in the primary care patient population, and primary care providers — including nurse practitioners — should be aware of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results